302 related articles for article (PubMed ID: 8062318)
21. [Kidney function in therapy with non-steroidal antiphlogistic drugs. A double-blind cross-over study with diclofenac, indomethacin and piroxicam].
Lang B; Hauk P; Meske S; Keller E; Peter HH
Z Rheumatol; 1991; 50(6):366-70. PubMed ID: 1796656
[TBL] [Abstract][Full Text] [Related]
22. Post hoc analysis of a randomized, double-blind, placebo-controlled efficacy and tolerability study of tramadol extended release for the treatment of osteoarthritis pain in geriatric patients.
Vorsanger G; Xiang J; Jordan D; Farrell J
Clin Ther; 2007; 29 Suppl():2520-35. PubMed ID: 18164919
[TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of valdecoxib in treating the signs and symptoms of severe rheumatoid arthritis: a 12-week, multicenter, randomized, double-blind, placebo-controlled study.
Gibofsky A; Rodrigues J; Fiechtner J; Berger M; Pan S
Clin Ther; 2007 Jun; 29(6):1071-85. PubMed ID: 17692722
[TBL] [Abstract][Full Text] [Related]
24. The effect of age on piroxicam disposition in rheumatoid arthritis.
Blocka KL; Richardson CJ; Wallace SM; Ross SG; Verbeeck RK
J Rheumatol; 1988; 15(5):757-63. PubMed ID: 3172091
[TBL] [Abstract][Full Text] [Related]
25. A comparison of valdecoxib and naproxen in the treatment of rheumatoid arthritis symptoms.
Williams GW; Kivitz AJ; Brown MT; Verburg KM
Clin Ther; 2006 Feb; 28(2):204-21. PubMed ID: 16678642
[TBL] [Abstract][Full Text] [Related]
26. A pharmacokinetic comparison of single doses of once-daily cyclobenzaprine extended-release 15 mg and 30 mg: a randomized, double-blind, two-period crossover study in healthy volunteers.
Darwish M; Chang S; Hellriegel ET
Clin Ther; 2009 Jan; 31(1):108-14. PubMed ID: 19243711
[TBL] [Abstract][Full Text] [Related]
27. [Pirprofen in the treatment of rheumatoid arthritis].
Ayrolles C; Fournie A
Nouv Presse Med; 1982 Aug; 11(33):2487-90. PubMed ID: 6752872
[TBL] [Abstract][Full Text] [Related]
28. A randomized double-blind placebo-controlled multicentre study to explore the efficacy and safety of tamsulosin and tolterodine in women with overactive bladder syndrome.
Robinson D; Cardozo L; Terpstra G; Bolodeoku J;
BJU Int; 2007 Oct; 100(4):840-5. PubMed ID: 17822465
[TBL] [Abstract][Full Text] [Related]
29. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses.
Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA
Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222
[TBL] [Abstract][Full Text] [Related]
30. Comparison of naproxen and piroxicam in the treatment of rheumatoid arthritis: a double-blind, crossover study.
Chlud K; Pangerl S
Pharmatherapeutica; 1985; 4(2):113-21. PubMed ID: 3903778
[TBL] [Abstract][Full Text] [Related]
31. Efficacy and tolerability of sustained-release tramadol in the treatment of symptomatic osteoarthritis of the hip or knee: a multicenter, randomized, double-blind, placebo-controlled study.
Malonne H; Coffiner M; Sonet B; Sereno A; Vanderbist F
Clin Ther; 2004 Nov; 26(11):1774-82. PubMed ID: 15639689
[TBL] [Abstract][Full Text] [Related]
32. Safety and efficacy of T-614 in the treatment of patients with active rheumatoid arthritis: a double blind, randomized, placebo-controlled and multicenter trial.
Lü LJ; Teng JL; Bao CD; Han XH; Sun LY; Xu JH; Li XF; Wu HX
Chin Med J (Engl); 2008 Apr; 121(7):615-9. PubMed ID: 18466681
[TBL] [Abstract][Full Text] [Related]
33. A pharmacokinetic and endoscopic comparison of an oral and an experimental buccal piroxicam formulation.
Mueller BA; Rex DK; Figueroa N; Greene P; Brater DC
Pharmacotherapy; 1992; 12(2):93-7. PubMed ID: 1570233
[TBL] [Abstract][Full Text] [Related]
34. [Efficacy and safety of long-acting carteolol 1% once daily. A double-masked, randomized study].
Trinquand C; Romanet JP; Nordmann JP; Allaire C;
J Fr Ophtalmol; 2003 Feb; 26(2):131-6. PubMed ID: 12660585
[TBL] [Abstract][Full Text] [Related]
35. A comparison of ketoprofen SR and sulindac in the elderly with rheumatoid arthritis.
Ahern MJ; Wetherall M; Leslie A; James RH; Roberts-Thomson PJ; Rennie GC
Br J Clin Pract; 1992; 46(4):229-33. PubMed ID: 1290729
[TBL] [Abstract][Full Text] [Related]
36. A randomized, placebo controlled trial of an antisense oligodeoxynucleotide to intercellular adhesion molecule-1 in the treatment of severe rheumatoid arthritis.
Maksymowych WP; Blackburn WD; Tami JA; Shanahan WR
J Rheumatol; 2002 Mar; 29(3):447-53. PubMed ID: 11908555
[TBL] [Abstract][Full Text] [Related]
37. Double-blind, multi-centre parallel trial of ketoprofen and ibuprofen in the treatment of rheumatoid arthritis.
Calin A; Bennett RM; Sukhupunyaraksa S; Goldman AL; Montoya HE; O'Brien WM; Giuliano VJ; Schmid FR; Willkens RF; Sakofsky HY
J Rheumatol; 1977; 4(2):153-7. PubMed ID: 328880
[TBL] [Abstract][Full Text] [Related]
38. Safety of tacrolimus in patients with rheumatoid arthritis: long-term experience.
Yocum DE; Furst DE; Bensen WG; Burch FX; Borton MA; Mengle-Gaw LJ; Schwartz BD; Wisememandle W; Mekki QA;
Rheumatology (Oxford); 2004 Aug; 43(8):992-9. PubMed ID: 15014199
[TBL] [Abstract][Full Text] [Related]
39. A double-blind, interpatient comparison of plain and slow-release ketoprofen in osteoarthritis.
Marcolongo R; Rubegni M; Provvedi D; Giordano N; Frati E; Bruni G
Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):377-81. PubMed ID: 6381334
[TBL] [Abstract][Full Text] [Related]
40. Once-weekly administration of 50 mg etanercept in patients with active rheumatoid arthritis: results of a multicenter, randomized, double-blind, placebo-controlled trial.
Keystone EC; Schiff MH; Kremer JM; Kafka S; Lovy M; DeVries T; Burge DJ
Arthritis Rheum; 2004 Feb; 50(2):353-63. PubMed ID: 14872476
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
